Syncom Formulations (India) Limited
Syncom Formulations (India) Limited (SYNCOMF-EQ) live share price today at NSE / BSE
Fri, 18 Sept 2026, 09:35 AM
About SYNCOMF-EQ
Syncom Formulations (India) Ltd is an Indian pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of healthcare formulations. Established in 1988 and headquartered in Mumbai, Syncom operates with a focus on both domestic and international pharmaceutical markets, serving over 20 countries across Africa, Southeast Asia, Latin America, and the CIS region. The company specializes in producing affordable, high-quality medicines, including tablets, capsules, oral liquids, ointments, and syrups, complemented by a diverse portfolio of allopathic and herbal products.
52 Week Range
Current Signal
green
Open
INR 18.80
High
INR 20.24
Low
INR 18.80
Prev. Close
INR 18.78
Volume
92,49,940
Avg. Volume (7D)
81,98,686
Avg. Volume (10D)
94,72,481
Latest Signal
BuyBuy Price
INR 19.3
Close Price
INR 19.94
Change
4.87%
Stoploss
INR 18.7
Signal Date
2026-09-18
Hold
Yes
Pattern
Three Outside Up
Company Snapshot
| CIN | L24239MH1988PLC047759 |
| Industry | Pharmaceuticals |
| Market Lot | 1 |
| Impact Cost | 0.21% |
| Listing Date | 17 Apr 1994 |
| BC Record Date | BC 24/09/2024-30/09/2024 |
| Registered Address | 7, Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (E) |
| Auditor | Sanjay Mehta and Associates |
Registrar
Shareholding Pattern
Quarterly filing · 30 Jun 2026
Board of Directors
Today Share Price
Syncom Formulations (India) Limited
| Particulars | Details |
|---|---|
| Opening Price | INR 18.80 |
| Previous Closing Price | INR 18.78 |
| Volume of Syncom Formulations (India) Limited | 92,49,940 |
| Value of Share | — |
Today NSE Share Price
Syncom Formulations (India) Limited
| Particulars | Details |
|---|---|
| Live Share Price NSE India | INR 19.94 |
| Previous Closing Price | INR 18.78 |
| Open Price | INR 18.80 |
| High | INR 20.24 |
| Low | INR 18.80 |
Today BSE Share Price
Syncom Formulations (India) Limited
| Particulars | Details |
|---|---|
| Live Share Price BSE India | INR 19.94 |
| Previous Closing Price | INR 18.78 |
| Open Price | INR 18.80 |
| High | INR 20.24 |
| Low | INR 18.80 |
Syncom Formulations (India) Limited
Syncom Formulations (India) Ltd is an Indian pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of healthcare formulations. Established in 1988 and headquartered in Mumbai, Syncom operates with a focus on both domestic and international pharmaceutical markets, serving over 20 countries across Africa, Southeast Asia, Latin America, and the CIS region. The company specializes in producing affordable, high-quality medicines, including tablets, capsules, oral liquids, ointments, and syrups, complemented by a diverse portfolio of allopathic and herbal products.
Leveraging accredited manufacturing facilities compliant with WHO-GMP standards, Syncom Formulations caters to government supply contracts, private institutions, and export markets, aligning its product pipeline with prevailing healthcare needs and evolving regulatory norms. The company’s integrated approach covers R&D, formulation, and large-scale production, positioning Syncom as a recognized supplier to national and international health agencies.
Frequently Asked Questions – StockYaari Stock Page
Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.
Final Thoughts
Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.
Track. Analyse. Outperform.
Your performance, our priority.

Platform Performance
(vs NIFTY 50)
Total Return
+24.35%
Outperformance
+12.41%
Accuracy
78%
Join 31,000+ active traders

Ready to unlock premium signals?
Sign in with your mobile number and start trading smarter today.

